NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ·Healthcare·Biotechnology
$7.26
+9.68%
Mkt Cap $11.22M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —
NASDAQ·Healthcare·Biotechnology
$7.26
+9.68%
Mkt Cap $11.22M
Buy
1
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —